Poolbeg-led consortium awarded €2.3m to develop oral vaccine platform
EncOVac, a consortium led by Poolbeg Pharma, has been awarded €2.3m ($2.4 million) in non-dilutive…
November 16, 2022 - 3 minutes
EncOVac, a consortium led by Poolbeg Pharma, has been awarded €2.3m ($2.4 million) in non-dilutive…